(Q30860547)

27 June 2017

The isolation and characterisation of human monoclonal HLA-A2 antibodies from an immune V gene phage display library (English)

1 reference

27 June 2017

0 references

1 reference

Watkins NA

1

1 reference

27 June 2017

Brown C

2

1 reference

27 June 2017

Hurd C

3

1 reference

27 June 2017

Navarrete C

4

1 reference

27 June 2017

Ouwehand WH

5

1 reference

27 June 2017

language of work or name

1 reference

1 March 2000

1 reference

27 June 2017

1 reference

27 June 2017

55

1 reference

27 June 2017

3

1 reference

27 June 2017

219-228

1 reference

Human monoclonal antibodies against blood group antigens preferentially express a VH4-21 variable region gene-associated epitope

27 June 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

Synthesis of Rh Fv phage-antibodies using VH and VL germline genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

Relationship of variable region genes expressed by a human B cell lymphoma secreting pathologic anti-Pr2 erythrocyte autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

V(D)J Recombination in Mature B Cells: A Mechanism for Altering Antibody Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

Receptor editing, immune diversification, and self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

The human antibody repertoire: heavy and light chain variable region gene usage in six alloantibodies specific for human HLA class I and class II alloantigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

By-passing immunization. Human antibodies from V-gene libraries displayed on phage

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

The human immunoglobulin VH repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

Combinatorial infection and in vivo recombination: a strategy for making large phage antibody repertoires

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

A human monoclonal antiphospholipid antibody that is representative of serum antibodies and is germline encoded

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

A directory of human germ-line V kappa segments reveals a strong bias in their usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

A novel approach to human anti-HLA mABs production: use of phage display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

Structure of the complex between human T-cell receptor, viral peptide and HLA-A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen–Ia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

RASMOL: biomolecular graphics for all

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

Molecular events during maturation of the immune response to oxazolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

The I Binding Specificity of Human VH4-34 (VH4-21) Encoded Antibodies is Determined by Both VHFramework Region 1 and Complementarity Determining Region 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

7 January 2021

V(D)J recombinase activity in a subset of germinal center B lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

7 January 2021

Nucleotide sequences of the variable regions of a human monoclonal antibody against HLA-A1, A23, and A24

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

7 January 2021

Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

7 January 2021

A Simple Method for Ranking the Affinities of Monoclonal Antibodies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

7 January 2021

The outline structure of the T-cell alpha beta receptor.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2000.550305.X

7 January 2021

10.1034/J.1399-0039.2000.550305.X

Identifiers

DOI

1 reference

27 June 2017

1 reference